HomeCompareSESN vs YUM

SESN vs YUM: Dividend Comparison 2026

SESN yields 318.07% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SESN wins by $2251.71M in total portfolio value
10 years
SESN
SESN
● Live price
318.07%
Share price
$0.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2251.82M
Annual income
$1,391,325,451.55
Full SESN calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — SESN vs YUM

📍 SESN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSESNYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SESN + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SESN pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SESN
Annual income on $10K today (after 15% tax)
$27,035.62/yr
After 10yr DRIP, annual income (after tax)
$1,182,626,633.82/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, SESN beats the other by $1,182,592,670.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SESN + YUM for your $10,000?

SESN: 50%YUM: 50%
100% YUM50/50100% SESN
Portfolio after 10yr
$1125.96M
Annual income
$695,682,704.44/yr
Blended yield
61.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

SESN
Analyst Ratings
5
Buy
3
Hold
Consensus: Buy
Altman Z
-26.2
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SESN buys
0
YUM buys
0
No recent congressional trades found for SESN or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSESNYUM
Forward yield318.07%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$2251.82M$107.0K
Annual income after 10y$1,391,325,451.55$39,957.33
Total dividends collected$2167.12M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold

Year-by-year: SESN vs YUM ($10,000, DRIP)

YearSESN PortfolioSESN Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$42,507$31,806.62$10,980$280.44+$31.5KSESN
2$171,836$126,354.35$12,185$435.72+$159.7KSESN
3$661,246$477,381.03$13,722$684.14+$647.5KSESN
4$2,424,371$1,716,837.53$15,773$1,090.14+$2.41MSESN
5$8,476,840$5,882,763.50$18,650$1,773.02+$8.46MSESN
6$28,293,724$19,223,504.84$22,921$2,966.37+$28.27MSESN
7$90,240,261$59,965,976.10$29,685$5,158.69+$90.21MSESN
8$275,301,033$178,743,953.65$41,216$9,453.02+$275.26MSESN
9$804,202,218$509,630,112.70$62,672$18,571.31+$804.14MSESN
10$2,251,821,824$1,391,325,451.55$107,016$39,957.33+$2251.71MSESN

SESN vs YUM: Complete Analysis 2026

SESNStock

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Full SESN Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this SESN vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SESN vs SCHDSESN vs JEPISESN vs OSESN vs KOSESN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.